Yosef Landesman

ScholarGPS® ID: 76355675463564

Affiliation

Rigshospitalet, Copenhagen, Denmark

Affiliation History

Field

Life Sciences

Discipline

Biology and Biological Sciences

Top Specialties

Metrics Summary

Publication Count

145

Predicted Citations

4,762

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export (journal article) Daneshmandi, Saeed \| Yan, Qi \| Choi, Jee Eun \| Katsuta, Eriko \| MacDonald, Cameron R. \| Goruganthu, Mounika \| Roberts, Nathan \| Repasky, Elizabeth A. \| Singh, Prashant K. \| Attwood, Kristopher \| ... \| Mohammadpour, Hemn Cellular & Molecular Immunology (2024). 10.1038/s41423-024-01187-1 Cite \| Source
Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model (journal article) Uddin, Md. Hafiz \| Al‐Hallak, Mohammad Najeeb \| Khan, Husain Yar \| Aboukameel, Amro \| Li, Yiwei \| Bannoura, Sahar F. \| Dyson, Gregory \| Kim, Seongho \| Mzannar, Yosef \| Azar, Ibrahim \| ... \| Azmi, Asfar S. Clinical and Translational Medicine, volume 13, issue 12 (2023). 10.1002/ctm2.1513 Cited by (2) \| Cite \| Source
NAD+ Metabolism Generates a Metabolic Vulnerability in Endocrine-Resistant Metastatic Breast Tumors in Females (journal article) Mogol, Ayca Nazli \| Zuo, Qianying \| Yoo, Jin Young \| Kaminsky, Alanna Zoe \| Imir, Ozan Berk \| Landesman, Yosef \| Walker, Christopher J \| Erdogan, Zeynep Madak Endocrinology, volume 164, issue 6 (2023). 10.1210/endocr/bqad073 Cited by (7) \| Cite \| Source
421 A Phase 1 and Randomized Phase 2 Clinical Trial of Selinexor and Temozolomide in Recurrent Glioblastoma Among Adults: The Product of a Successful Team Science Approach (journal article) Chow, Frances \| Berens, Michael \| Tamir, Sharon \| Landesman, Yosef \| Walker, Christopher \| Krailo, Mark \| Gore, Steven \| Portnow, Jana Journal of Clinical and Translational Science, volume 7, issue s1, pages 126-126 (2023). 10.1017/cts.2023.454 Cite \| Source
Sequential Administration of Selinexor then CD19 CAR-T Cells Exhibits Enhanced Efficacy in a Mouse Model of Human Non-Hodgkin's Lymphoma (journal article) Stadel, Ryan \| Liu, Ruifu \| Landesman, Yosef \| Wald, David \| Hosahalli Vasanna, Smitha \| de Lima, Marcos J.G. Blood, volume 140, issue Supplement 1, pages 7413-7414 (2022). 10.1182/blood-2022-164443 Cited by (2) \| Cite \| Source
ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors (journal article) Mogol, Ayca \| Chien, Christine \| Zuo, Qianying \| Singareeka Raghavendra, Akshara \| Tripathy, Debu \| Landesman, Yosef \| Madak-Erdogan, Zeynep Journal of the Endocrine Society, volume 6, issue Supplement_1, pages A879-A879 (2022). 10.1210/jendso/bvac150.1819 Cite \| Source
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML (journal article) Pianigiani, Giulia \| Gagliardi, Andrea \| Tini, Valentina \| Bigerna, Barbara \| Caruso, Simona \| Marra, Andrea \| Shacham, Sharon \| Landesman, Yosef \| Quintarelli, Concetta \| Locatelli, Franco \| ... \| Brunetti, Lorenzo Clinical Lymphoma Myeloma and Leukemia, volume 22 (2022). 10.1016/S2152-2650(22)01220-4 Cite \| Source
Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms (journal article) Walker, Christopher J. \| Chang, Hua \| Henegar, Leah \| Kashyap, Trinayan \| Shacham, Sharon \| Sommer, Josh \| Wick, Michael J. \| Levy, Joan \| Landesman, Yosef Frontiers in Oncology, volume 12 (2022). 10.3389/fonc.2022.808021 Cited by (3) \| Cite \| Source
Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival (journal article) Rangel‐Moreno, Javier \| Garcia‐Hernandez, Maria de la Luz \| Owen, Teresa \| Barnard, Jennifer \| Becerril‐Villanueva, Enrique \| Kashyap, Trinayan \| Argueta, Christian \| Gamboa‐Dominguez, Armando \| Tamir, Sharon \| Landesman, Yosef \| ... \| Anolik, Jennifer H. Arthritis & Rheumatology, volume 74, issue 8, pages 1363-1375 (2022). 10.1002/art.42128 Cited by (1) \| Cite \| Source
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma (journal article) Restrepo, Paula \| Bhalla, Sherry \| Ghodke-Puranik, Yogita \| Aleman, Adolfo \| Leshchenko, Violetta \| Melnekoff, David T. \| Agte, Sarita \| Jiang, Joy \| Madduri, Deepu \| Richter, Joshua \| ... \| Parekh, Samir JCO Precision Oncology (2022). 10.1200/PO.22.00147 Cited by (10) \| Cite \| Source
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers (journal article) Khan, Husain Yar \| Nagasaka, Misako \| Li, Yiwei \| Aboukameel, Amro \| Uddin, Md. Hafiz \| Sexton, Rachel \| Bannoura, Sahar \| Mzannar, Yousef \| Al-Hallak, Mohammed Najeeb \| Kim, Steve \| ... \| Azmi, Asfar S. Cancer Research Communications, volume 2, issue 5, pages 342-352 (2022). 10.1158/2767-9764.CRC-21-0176 Cited by (13) \| Cite \| Source
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma (journal article) Lassman, Andrew B. \| Wen, Patrick Y. \| van den Bent, Martin J. \| Plotkin, Scott R. \| Walenkamp, Annemiek M.E. \| Green, Adam L. \| Li, Kai \| Walker, Christopher J. \| Chang, Hua \| Tamir, Sharon \| ... \| Mau-Sørensen, Morten Clinical Cancer Research, volume 28, issue 3, pages 452-460 (2022). 10.1158/1078-0432.CCR-21-2225 Cited by (33) \| Cite \| Source
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma (journal article) Cornell, Robert Frank \| Baz, Rachid \| Richter, Joshua R. \| Rossi, Adriana \| Vogl, Dan T. \| Chen, Christine \| Shustik, Chaim \| Alvarez, Mariano J. \| Shen, Yao \| Unger, T. J. \| ... \| Hofmeister, Craig C. American Journal of Hematology, volume 97, issue 2 (2022). 10.1002/ajh.26420 Cited by (12) \| Cite \| Source
A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem Cell Transplantation (journal article) Cass, Michael \| McDonald, Andrew B. \| Ben-Shahar, Osnat \| Landesman, Yosef \| Kashyap, Trinayan American Journal of Case Reports, volume 23 (2022). 10.12659/AJCR.935353 Cited by (2) \| Cite \| Source
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma (journal article) Mouhieddine, Tarek H. \| Parekh, Samir \| Cho, Hearn Jay \| Richter, Joshua \| DeCastro, Andrew \| Shah, Jatin \| Landesman, Yosef \| Chari, Ajai \| Jagannath, Sundar \| Madduri, Deepu Annals of Hematology, volume 100, issue 12, pages 3057-3060 (2021). 10.1007/s00277-020-04293-y Cited by (2) \| Cite \| Source
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models (journal article) Handley, Katelyn F. \| Rodriguez-Aguayo, Cristian \| Ma, Shaolin \| Stur, Elaine \| Joseph, Robiya \| Bayraktar, Emine \| Dasari, Santosh K. \| Nguyen, Nghi \| Powell, Reid T. \| Sobieski, Mary \| ... \| Sood, Anil K. Molecular Cancer Therapeutics, volume 20, issue 12, pages 2352-2361 (2021). 10.1158/1535-7163.MCT-21-0370 Cited by (8) \| Cite \| Source
A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia (journal article) Sweet, Kendra \| Bhatnagar, Bhavana \| Döhner, Hartmut \| Donnellan, Will \| Frankfurt, Olga \| Heuser, Michael \| Kota, Vamsi \| Liu, Hongtao \| Raffoux, Emmanuel \| Roboz, Gail J. \| ... \| Montesinos, Pau Leukemia & Lymphoma, volume 62, issue 13, pages 3192-3203 (2021). 10.1080/10428194.2021.1950706 Cited by (8) \| Cite \| Source
Transcriptomic Correlates of Response to Selinexor in Multiple Myeloma Reveal a Predictive Signature (journal article) Restrepo, Paula \| Bhalla, Sherry \| Aleman, Adolfo \| Leshchenko, Violetta \| Agte, Sarita \| Ghodke-Puranik, Yogita \| Jiang, Joy \| Stevens, Mark M. \| Madduri, Deepu \| Richter, Joshua \| ... \| Parekh, Samir Blood, volume 138, issue Supplement 1, pages 457-457 (2021). 10.1182/blood-2021-150522 Cited by (1) \| Cite \| Source
Dual Targeting PAK4 and NAMPT As a Novel Therapeutic Approach for Aggressive Non-Hodgkin's Lymphoma (journal article) Balasubramanian, Suresh Kumar \| Khan, Husain \| Uddin, Md. Hafiz \| Aboukameel, Amro \| Li, Yiwei \| Zonder, Jeffrey A. \| Senapedis, William T. \| Baloglu, Erkan \| Mohammad, Ramzi \| Shah, Jatin J. \| ... \| Azmi, Asfar Sohail Blood, volume 138, issue Supplement 1, pages 683-683 (2021). 10.1182/blood-2021-145615 Cite \| Source
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus (journal article) Mpilla, Gabriel B. \| Uddin, Md. Hafiz \| Al-Hallak, Mohammed N. \| Aboukameel, Amro \| Li, Yiwei \| Kim, Steve H. \| Beydoun, Rafic \| Dyson, Gregory \| Baloglu, Erkan \| Senapedis, William T. \| ... \| Azmi, Asfar S. Molecular Cancer Therapeutics, volume 20, issue 10, pages 1836-1845 (2021). 10.1158/1535-7163.MCT-20-1105 Cited by (14) \| Cite \| Source